These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11129672)

  • 1. Specialized heart failure centers--a success or an indicator of the failure of our health care delivery system.
    Pitt B; Nicklas JM
    Clin Cardiol; 2000 Dec; 23(12):881-2. PubMed ID: 11129672
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?
    Scheiner MA; Kimmel SE
    J Gen Intern Med; 1997 Sep; 12(9):581-2. PubMed ID: 9294792
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure.
    Ramahi TM; Longo MD; Rohlfs K; Sheynberg N
    Clin Cardiol; 2000 Dec; 23(12):909-14. PubMed ID: 11129677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
    Kasje WN; Denig P; Stewart RE; de Graeff PA; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2005 Apr; 61(2):145-51. PubMed ID: 15761751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
    Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
    Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
    Houghton AR; Cowley AJ
    Int J Cardiol; 1997 Mar; 59(1):7-10. PubMed ID: 9080020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
    Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction?
    Bailey LJ; Naganathan V
    Med J Aust; 2007 Jan; 186(2):99-100; author reply 100-101. PubMed ID: 17223774
    [No Abstract]   [Full Text] [Related]  

  • 10. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
    Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A taxonomy of reasons for not prescribing guideline-recommended medications for patients with heart failure.
    Steinman MA; Patil S; Kamat P; Peterson C; Knight SJ
    Am J Geriatr Pharmacother; 2010 Dec; 8(6):583-94. PubMed ID: 21356507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient healthcare utilization 30 days before and after hospitalization for heart failure in France: Contribution of the national healthcare database (Systèmenationaldesdonnéesdesanté).
    Feldman SF; Lesuffleur T; Olié V; Gastaldi-Ménager C; Juillière Y; Tuppin P
    Arch Cardiovasc Dis; 2020; 113(6-7):401-419. PubMed ID: 32473996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of Performance and Outcome Measures for Heart Failure.
    Patel J; Sandhu A; Parizo J; Moayedi Y; Fonarow GC; Heidenreich PA
    Circ Heart Fail; 2018 Sep; 11(9):e005035. PubMed ID: 30354367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of the RALE study. Hyperkalemia following spironolactone treatment].
    Erdmann E
    Internist (Berl); 2005 Apr; 46(4):466, 468. PubMed ID: 15723149
    [No Abstract]   [Full Text] [Related]  

  • 16. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
    Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
    Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition in heart failure: clinical trials and clinical practice.
    Squire lB
    Cardiovasc Drugs Ther; 2002 Jan; 16(1):67-74. PubMed ID: 12085981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving ACE inhibitor use in patients hospitalized with systolic heart failure: a cluster randomized controlled trial of clinical practice guideline development and use.
    Thilly N; Briançon S; Juillière Y; Dufay E; Zannad F
    J Eval Clin Pract; 2003 Aug; 9(3):373-82. PubMed ID: 12895159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
    Johnson D; Jin Y; Quan H; Cujec B
    J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of primary health care in 15 different countries. Examination and treatment of patients with heart failure should be better].
    Cline C; Boman K; Swedberg K
    Lakartidningen; 2003 Apr; 100(14):1242-3. PubMed ID: 12756653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.